Notably, the YQHXJDD ELNVs group displayed the highest CD4/CD8 ratio, suggesting that YQHXJDD ELNVs can alleviate the immunosuppressive tumor microenvironment and enhance T cell-mediated immune activity. This evidence concerns the gene CD4 and neoplasm.